Conversion Exercise of CB Results in 1.19% Dilution, Listing Date Adjusted to Apr 27; Neutral Impact as Conversion Price Aligns with Market


  • Correction filing: Listing date for conversion of 1st series CB changed from Apr 20 to Apr 27, 2026 due to agency schedule
  • Conversion details: KRW 2B out of total KRW 20B CB exercised, issuing 211,014 shares at conversion price KRW 9,478
  • Dilution: 1.19% dilution relative to existing shares (17,752,276); remaining unconverted balance of KRW 18B (conversion price KRW 9,478) implies potential future dilution
  • Price impact: Current price KRW 9,470 near conversion price KRW 9,478, limiting conversion incentive; dilution is modest
  • [AI Summary]The conversion exercise results in a minor dilution of 1.19%, but the conversion price is aligned with the market price, limiting shareholder value erosion. The remaining KRW 18B unconverted CB poses potential future dilution, but immediate price impact is constrained

KOSDAQ Filing Information


  • Filing: [Correction of Description] Exercise of Conversion Rights
  • Company: GC WellBeing (234690)
  • Submission: GC WellBeing Corporation
  • Receipt: 04-15-2026
  • Under KRX KOSDAQ Market Division, Amended (Refer to related filing)